Glenmark Pharmaceuticals standalone net profit rises 96.81% in the September 2024 quarter
Sales rise 19.56% to Rs 2594.89 crore
Net profit of Glenmark Pharmaceuticals rose 96.81% to Rs 595.06 crore in the quarter ended September 2024 as against Rs 302.35 crore during the previous quarter ended September 2023. Sales rose 19.56% to Rs 2594.89 crore in the quarter ended September 2024 as against Rs 2170.40 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales2594.892170.40 20 OPM %30.0120.43 -PBDT849.91458.89 85 PBT795.06409.04 94 NP595.06302.35 97Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2024 | 7:42 AM IST